- Zacks•10 days ago
Momenta Pharmaceuticals, Inc. (MNTA) entered into an exclusive research collaboration and worldwide license agreement with CSL Limited.
- Zacks•11 days ago
Roche Holding AG (RHHBY) announced today that the FDA has approved a label expansion of ophthalmology drug Lucentis- fifth indication.
- Zacks•11 days agoZacks.com featured highlights: Braskem, Cambrex, Daqo New Energy, State National Companies and International Consolidated Airlines Group
Zacks.com featured highlights: Braskem, Cambrex, Daqo New Energy, State National Companies and International Consolidated Airlines Group
CBM : Summary for Cambrex Corporation Common Stoc - Yahoo Finance
Cambrex Corporation (CBM)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||55.40 - 57.00|
|52 Week Range||29.50 - 59.41|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||29.49|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|